OphthaliX : European Patent Office Grants a Patent for the Treatment of Sjogren’s Syndrome

– – Israeli OphthaliX Inc. (OTC BB: OPLID),  announced that the European Patent Office issued a Certificate of Grant of Patent for European Patent No. 1778239 entitled “Adenosine A3 receptor More...